Bioequivalence of Cladribine 10 mg from two different products
CPO23001
Phase 1 other active
Quick answer
Bioequivalence of Cladribine 10 mg from two different products for No therapeutic indication in the current trial with healthy volunteers. The intended indication is for treatment of adult patients with highly active relapsing multiple sclerosis (MS). is a Phase 1 program (other) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- No therapeutic indication in the current trial with healthy volunteers. The intended indication is for treatment of adult patients with highly active relapsing multiple sclerosis (MS).
- Phase
- Phase 1
- Modality
- other
- Status
- active